SCHEMBL3708315

SCHEMBL3708315

O=S(=O)(O)c1ccccc1Cl.[KH]

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 4/20 0.46
▸ TSHR P16473 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MYC P01106 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NFE2L2 Q16236 4/20 0.42
▸ POLB P06746 1/20 0.41
▸ SLC1A3 P43003 1/20 0.41
▸ SLC1A2 P43004 1/20 0.41
▸ SLC1A1 P43005 1/20 0.41
▸ FLT1 P17948 1/20 0.41
▸ FLT4 P35916 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TTR P02766 1/20 0.41
▸ AKR1B1 P15121 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30454753 0.98 HSD11B1 (0.47) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL50612 0.98 HSD11B1 (0.47) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL6908684 0.95 HSD11B1 (0.46) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL6913307 0.95 HSD11B1 (0.46) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL6908686 0.95 HSD11B1 (0.46) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL3709429 0.95 HSD11B1 (0.46) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL6913968 0.95 HSD11B1 (0.46) HSD11B1TSHRALDH1A1GAAHSD17B10
Ammonia Solution, Strong SCHEMBL11794102 0.95 HSD11B1 (0.46) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL2880274 0.95 HSD11B1 (0.50) HSD11B1TSHRALDH1A1GAAHSD17B10
SCHEMBL6917692 0.95 HSD11B1 (0.46) HSD11B1TSHRALDH1A1GAAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2460789-B1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL CO (JP) 2017-04-19 — — EP disclosed
US-9079830-B2 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-14 — — US disclosed
CN-103112874-B Separating and recovering process for solid wastes JINGBO AGROCHEMICALS TECHNOLOGY CO LTD 2014-08-27 — — CN disclosed
CN-103112874-A Separating and recovering process for solid wastes JINGBO AGROCHEMICALS TECHNOLOGY CO LTD 2013-05-22 — — CN disclosed
EP-2460789-A1 METHOD FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2012-06-06 — — EP disclosed
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND AKR7A2, AOC2, CBR1 HSD11B1 119/4885TSHR 1160/4885ALDH1A1 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback